Dow Falls 200 Points After Worse-Than-Feared Inflation Data And Johnson & Johnson Vaccine Concerns

Dow Falls 200 Points After Worse-Than-Feared Inflation Data And Johnson & Johnson Vaccine Concerns

Topline

Stocks are mixed near record highs Tuesday as investors largely brush off firmer-than-anticipated inflation data and a potential blow to the nation's inoculation efforts, focusing instead on the Wednesday start of first-quarter earnings season, which will shed light on how corporations have been faring as the economy reopens.

A trader works on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Wednesday, ... [+] Feb. 26, 2020. U.S. equities swung between gains and losses as investors digested fresh evidence of the widening coronavirus outbreak. Photographer: Michael Nagle/Bloomberg



© 2020 Bloomberg Finance LP



Key Facts





Shortly after the market open, the Dow Jones Industrial Average and the S&P 500—both of which were virtually flat Monday after closing out last week at record highs—fell 181 points, or 0.5%, and 0.1%, respectively, while the tech-heavy Nasdaq jumped 0.4%.





Shares of Johnson & Johnson are slumping more than 2% after officials at the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) called for a pause on the administration of its Covid-19 vaccine over rare blood clot cases;